Sun Pharmaceutical Industries Limited Long-Term Growth Calculator: ROI, CAGR & Dividend Tracker

Investment Scenario

Sun Pharmaceutical Industries Limited share price on Jan 5, 2015  

Share Price          : ₹830.05
Total Share Bought   : 120 shares
Invested Amount      : ₹99606.00

In 2015, an investor has ₹100,000.00 and wants to invest in Sun Pharmaceutical Industries Limited (SUNPHARMA). At that time, the stock price of Sun Pharmaceutical Industries Limited is ₹830.05 per share, allowing the investor to purchase 120 shares for a total of ₹99606.00. This leaves the investor with ₹394.00 remaining from the initial ₹100,000.00.
Instead of chasing short-term gains, the investor adopted a long-term approach—holding the shares for 10 years without selling. Over time, the value of the investment grew not only through stock price appreciation but also through the accumulation of dividend payouts.

Sun Pharmaceutical Industries Limited share price on Aug 29, 2025 

Share Price of    : ₹1594.5
Total Share       : 120 shares (including stock splits, if any) 
Investment Value  : ₹191,340.00

As of Aug 29, 2025, the ₹99,606.00 investment in NSE:SUNPHARMA would be worth approximately ₹191,340.00 , thanks to stock splits, price appreciation, and consistent dividend payouts. This reflects a total Gain from stocks of ₹91,734.00, a return on investment (ROI) of 101.10%, and an annualized compounded growth rate (CAGR) of around 7.24%. This highlights the power of long-term investing and shows how a disciplined, patient approach—paired with investing in a fundamentally strong company like Sun Pharmaceutical Industries Limited (SUNPHARMA)—can lead to significant wealth creation over time.

Wealth grew over time through a mix of dividend income and stock price appreciation. Dividends added to capital, while stock splits increased the number of shares held. Even without reinvesting dividends, the portfolio expanded steadily. As years passed, compounding took effect — turning small gains into larger ones. Holding the stock long-term allowed capital to grow naturally. This shows how patience, steady returns, and the power of compounding can help build lasting wealth from a single investment.

Sun Pharmaceutical Industries Limited Investment Summary (2015–2025)

   
 
 By Aug 29, 2025, the share price increased to ₹1594.50.
 This resulted in a significant appreciation in the value of the investment.
 

 

This performance reflects a Compound Annual Growth Rate (CAGR) of Sun Pharmaceutical Industries Limited stock, approximately 7.24% 
 — a strong return over the period.

Yearly Breakdown

SUNPHARMA 10 years Investment Performance Overview

Sun Pharmaceutical Industries Limited (Ticker: SUNPHARMA) is a 3.826T (Large-Cap) Drug Manufacturers company in the Healthcare sector, listed on the NSE. With a market capitalization of ₹3.826T (Large-Cap), a PE ratio of 36.77, and an EPS of 43.37, SUNPHARMA remains one of India’s most stable and well-established companies.

If we have a look at SUNPHARMA's stock performance in last one year, it has traded between a 52-week low of ₹1,553.05 and a high of ₹1,960.35 per share.

If you had invested ₹99,606.00 in Sun Pharmaceutical Industries Limited (SUNPHARMA) 10 years ago, your portfolio would have grown significantly by Aug 29, 2025:

• Initial investment: ₹99,606.00
• Stock Gain: ₹91.7K
• Total Dividends received: ₹8970.00
• Total return (Stock Gain + Dividends): ₹100,704.00
• Final Portfolio Value (Initial + Stock Gain + Dividends): ₹200,310.00

This journey shows that SUNPHARMA has not only delivered steady capital appreciation but also rewarded shareholders through consistent dividend payouts, making it a strong long-term wealth compounder in the Indian stock market.